Psychedelic Medicine Task Force
GLOW is actively advocating for the creation of a state-sanctioned Psychedelic Medicine Task Force—a multidisciplinary advisory body dedicated to exploring the therapeutic potential, safety, and regulatory pathways for psychedelic-assisted treatments in Idaho. This initiative is especially urgent in light of Idaho HJR 4, a proposed 2026 constitutional amendment that would ban citizen-led initiatives related to marijuana, narcotics, and other psychoactive substances. By establishing a task force now, Idaho can make informed, science-based decisions that prioritize public health, safety, and compassionate care.
👉 Learn more about the 2026 ballot measure here.
Minnesota
Task Force: Psychedelic Medicine Task Force
Established: 2023
Purpose: To advise the legislature on legal, medical, and policy issues related to potential legalization of psychedelic medicine.
Key Actions: Released a comprehensive report recommending decriminalization of psilocybin and further research into therapeutic uses.
More Info: Minnesota Department of Health (click here)
Utah
Task Force: Mental Illness Psychotherapy Drug Task Force
Established: 2022
Purpose: To study the therapeutic potential of certain drugs, including psilocybin, for mental health treatment.
Key Actions: Recommended waiting for FDA approval before proceeding with psychedelic-assisted therapy programs.
More Info: Utah Patients Coalition (click here)
Texas
Task Force: Psilocybin Research Advisory Council.
Established: 2021
Purpose: To advise the state on psilocybin research and treatment, particularly for veterans with PTSD.
Key Actions: Formed under House Bill 4423 to explore medical applications of psychedelics before legislative changes.
More Info: Texas Legislature Online (click here)
Washington State
Task Force: Psilocybin Task Force
Established: 2023
Purpose: To study clinical information about psilocybin use and discuss regulatory structures for clinical use.
Key Actions: Mandated by Senate Bill 5263 to issue a final report with recommendations.
More Info: Washington State Health Care Authority (click here)
Alaska
Task Force: Task Force for the Regulation of FDA Approved Psychedelic Medicines
Established: 2024
Purpose: To assess the potential use of psychedelic medicine in addressing the state's mental health crisis and prepare for potential federal approval of psychedelic therapies.
Key Actions: Created under House Bill 228 to explore regulatory frameworks and equitable access.
More Info: Alaska Public Media (click here)
